scholarly journals Technology-based interventions for the treatment and recovery management of substance use disorders: A JSAT special issue

2014 ◽  
Vol 46 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Lisa A. Marsch ◽  
Kathleen M. Carroll ◽  
Brian D. Kiluk
Author(s):  
Esra Alagoz ◽  
Kim Johnson ◽  
Andrew Quanbeck ◽  
David Gustafson

Late-life addiction has been a neglected topic in the field of substance-use disorders research. Research suggests that with the aging baby-boomer generation, decline in fertility rates, and increases in life expectancy, there will be an increasing demand on the substance-abuse treatment systems designed specifically for individuals aged 65 and older in the next decade. Emerging technologies such as electronic health records, dashboards, communication tools, and new-generation monitoring devices offer significant opportunities to advance the treatment and recovery management of substance use disorders. This chapter explains the emerging technologies that are being used in addiction treatment and proposes guidelines for how these systems can be adopted for older adults by drawing on experiences from ElderTree, an interactive health technology designed for older populations.


CNS Spectrums ◽  
2018 ◽  
Vol 24 (1) ◽  
pp. 102-113 ◽  
Author(s):  
Tatiana Ramey ◽  
Paul S. Regier

Cognitive impairments in substance use disorders have been extensively researched, especially since the advent of cognitive and computational neuroscience and neuroimaging methods in the last 20 years. Conceptually, altered cognitive function can be viewed as a hallmark feature of substance use disorders, with documented alterations in the well-known “executive” domains of attention, inhibition/regulation, working memory, and decision-making. Poor cognitive (sometimes referred to as “top-down”) regulation of downstream motivational processes—whether appetitive (reward, incentive salience) or aversive (stress, negative affect)—is recognized as a fundamental impairment in addiction and a potentially important target for intervention. As addressed in this special issue, cognitive impairment is a transdiagnostic domain; thus, advances in the characterization and treatment of cognitive dysfunction in substance use disorders could have benefit across multiple psychiatric disorders. Toward this general goal, we summarize current findings in the abovementioned cognitive domains of substance use disorders, while suggesting a potentially useful expansion to include processes that bothprecede(precognition) andsupersede(social cognition) what is usually thought of as strictly cognition. These additional two areas have received relatively less attention but phenomenologically and otherwise are important features of substance use disorders. The review concludes with suggestions for research and potential therapeutic targeting of both the familiar and this more comprehensive version of cognitive domains related to substance use disorders.


Sign in / Sign up

Export Citation Format

Share Document